Ketamine for Refractory Status Epilepticus: A Systematic Review

@article{Rosati2018KetamineFR,
  title={Ketamine for Refractory Status Epilepticus: A Systematic Review},
  author={Anna Rosati and Salvatore De Masi and Renzo Guerrini},
  journal={CNS Drugs},
  year={2018},
  volume={32},
  pages={997-1009}
}
BackgroundKetamine is an emerging third-line medication for refractory status epilepticus, a medical and neurological emergency requiring prompt and appropriate treatment. Owing to its pharmacological properties, ketamine represents a practical alternative to conventional anaesthetics.ObjectiveThe objective of this study was to assess the efficacy and safety of ketamine to treat refractory status epilepticus in paediatric and adult populations.MethodsWe conducted a literature search using the… Expand
Efficacy and Safety of Ketamine in Refractory/Super-refractory Nonconvulsive Status Epilepticus: Single-Center Experience
TLDR
Ketamine appears to be a promising drug in r/srNCSE, and earlier and prolonged infusion, as well as combination with benzodiazepines may increase its efficacy. Expand
The Unease When Using Anesthetics for Treatment-Refractory Status Epilepticus: Still Far Too Many Questions.
  • P. Opic, R. Sutter
  • Medicine
  • Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
  • 2020
TLDR
Clinicians should deliberately weigh the advantages and disadvantages of intravenous anesthetic drug therapy in patients with different types of SE usually linked to a favorable outcome (i.e., simple partial, complex partial, or absence seizures). Expand
Efficacy of Home Anticonvulsant Administration for Second-Line Status Epilepticus Treatment
TLDR
This study provides Class II evidence that for patients with refractory convulsive status epilepticus, use of a home second-line anticonvulsant compared to a non-home anticonVulsant did not significantly affect the probability of stopping seizures. Expand
Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review
TLDR
The evidence for the use of ASDs in RSE beyond that in current guidelines is low, but several effective and well-tolerated options are available that should be considered in this patient population. Expand
A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care
TLDR
Electroencelography can identify patterns of burst suppression, which may be a target to guide weaning of intravenous therapy and a flow chart outlining the timing and dosage of anaesthetic agents used at the institution is provided. Expand
Antiepileptic Drug Therapy for Status Epilepticus
  • Daeyoung Kim, Jae Moon Kim, +8 authors Keun Tae Kim
  • Medicine
  • Journal of clinical neurology
  • 2021
TLDR
Evidence of good quality supports the use of benzodiazepines as the first-line treatment of SE, but evidence informing the administration of second- or third-line treatments is lacking; hence, the recommendations presented herein concerning the treatment of established and refractory SE are based on case series and expert opinions. Expand
Anesthetic Use In Status Epilepticus: A Concise Review
TLDR
The pharmacology, dosages, major side effects, and clinical use of IV anesthetics in the treatment of SE with an emphasis on the developing literature supporting the use of ketamine for this indication. Expand
Ketamine in seizure management and future pharmacogenomic considerations
TLDR
It is demonstrated that IV ketamine can be transitioned to oral regimen to shorten length of stay in the intensive care unit and hospital and has future CYP2B6 pharmacogenomic considerations for further dose individualization. Expand
Review and Updates on the Treatment of Refractory and Super Refractory Status Epilepticus
TLDR
This review focuses on the diagnosis and treatment of RSE and SRSE, which are life-threatening conditions requiring prompt initiation of appropriate treatment to avoid permanent neurological damage and reduce morbidity and mortality. Expand
Ketamine use for super-refractory status epilepticus in children.
TLDR
Ketamine utility in SRSE and acceptance among intensivists is still variable, and recent studies have suggested that with prolonged seizures, the number of activated γ-aminobutyric acid type A (GABAA) receptors on the postsynaptic membrane gradually decreases while theNumber of inactive GABAA receptors increases, which might explain the loss of efficacy of anticonvulsants in prolonged seizures that act on GABAergic system, such as benzodiazepines. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 80 REFERENCES
Ketamine use in the treatment of refractory status epilepticus
TLDR
It is suggested that ketamine may be a safe and efficacious adjunctive agent in the treatment of RSE and six of the seven patients (85%) who required vasopressors during early treatment for RSE were able to be weaned from vasopressing during ketamine infusion. Expand
Treatment of refractory status epilepticus: literature review and a proposed protocol.
TLDR
A sample treatment algorithm is presented that emphasizes the need for rapid therapeutic intervention, employs consecutive medications with different mechanisms of action, and attempts to minimize the risk of hypotension. Expand
Super-Refractory Status Epilepticus: A Therapeutic Challenge in Paediatrics.
TLDR
All three children were aged 6-7 years with prior normal developmental history and no medical illness, and had residual neurological deficits and morbidities like pneumonia and sepsis, which constituted a therapeutic challenge. Expand
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study
TLDR
Treatment of SRSE in adult patients with (S)-KET led to resolution of status in 64 %. Expand
Ketamine Continuous Infusion for Refractory Status Epilepticus in a Patient With Anticonvulsant Hypersensitivity Syndrome
TLDR
A previously healthy 27-year-old woman who presented with prolonged RSE requiring the initiation of multiple AEDs, including high-dose propofol and midazolam continuous infusions is described. Expand
Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation
TLDR
Ketamine is effective in treating RCSE and represents a practical alternative to conventional anesthetics for the treatment of RCSE, avoiding the pitfalls and dangers of endotracheal intubation. Expand
Effectiveness of Electroconvulsive Therapy for Refractory Status Epilepticus in Febrile Infection‐Related Epilepsy Syndrome
TLDR
A case in which ECT was successfully used for treatment of refractory SE in a pediatric patient with FIRES syndrome is reported, in which conventional antiepileptic drugs fail to control SE in FIRES patients. Expand
Ketamine infusion for refractory status epilepticus: A case report of cardiac arrest
TLDR
Ketamine is utilized to treat refractory status epilepticus, but should be used with caution in patients with subarachnoid hemorrhage, as there may be an increased risk of life threatening arrhythmias and cardiac arrest. Expand
Propofol–ketamine combination therapy for effective control of super-refractory status epilepticus
TLDR
The overall SRSE resolution rate was 91%, and the overall mortality including patients with anoxic brain injury was 39%, which was the primary determinant of mortality. Expand
Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient
TLDR
Rebound refractory NCSE occurred about six days after discontinuing the intravenous ketamine, which was successfully terminated by oral ketamine treatment, and there were no adverse effects observed. Expand
...
1
2
3
4
5
...